ATLASInvesco S&P International Developed Quality ETF (IDHQ): outlook, holdings and fees
Invesco S&P International Developed Quality ETF (IDHQ) is an exchange-traded fund and is managed by Invesco. The expense ratio is 0.30% and the yield is 1.92%. The ten largest holdings are 34% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on IDHQ
| Last price | $44.46 (+1.0%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 56% |
| Likely 1-month range (50%) | $43.67 – $45.73 |
| Normal 1-day range (±1σ) | ±0.8% |
| Distribution yield | 1.92% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
IDHQ fund facts
| Issuer | Invesco |
|---|---|
| Theme | International developed |
| Assets under management | $1.1B |
| Expense ratio | 0.30% |
| Number of holdings | 50 |
| Portfolio turnover | 0% |
| Inception | Jun 13, 2007 |
| Exchange | NYSE |
The fund will invest at least 90% of its total assets in securities that comprise the underlying index. The index provider compiles, maintains and calculates the underlying index, which is composed of constituents of the S&P Developed ex-U.S. LargeMidCap Index that the index provider identifies as being of the highest quality-that is, stocks of companies that seek to generate higher revenue and cash flow than their counterparts through prudent use of assets and finances.
IDHQ top holdings
| Holding | Sector | Weight |
|---|---|---|
| Roche Holding AG ROP | Healthcare | 5.14% |
| ASML Holding N.V. ASML | Technology | 4.81% |
| Novartis AG NOVN | Healthcare | 4.42% |
| Nestle S.A. NESN | Consumer Defensive | 3.29% |
| Advantest Corp. 6857 | Technology | 3.23% |
| SAP SE SAP | Technology | 3.04% |
| Rolls-Royce Holdings PLC RR | Industrials | 2.63% |
| Recruit Holdings Co Ltd 6098 | Communication Services | 2.59% |
| ABB Ltd ABBN | Industrials | 2.54% |
| Allianz SE VNA O.N. ALV | Financial Services | 2.39% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
IDHQ sector breakdown
| Sector | Weight |
|---|---|
| Industrials | 20.3% |
| Technology | 20.3% |
| Healthcare | 16.6% |
| Financial Services | 14.9% |
| Consumer Defensive | 8.4% |
| Consumer Cyclicals | 7.4% |
| Basic Materials | 5.3% |
| Communication Services | 3.6% |
| Energy | 3.1% |
| Utilities | 0.2% |
By region: Europe Developed 57.3%, Japan 17.4%, United Kingdom 10.1%, North America 7.4%, Asia Developed 3.6%.
IDHQ returns and risk
| Year to date | +26.2% |
|---|---|
| 1 year | +31.3% |
| 3 years (annualised) | +20.5% |
| 5 years (annualised) | +10.5% |
| 10 years (annualised) | +10.5% |
| Volatility (3 years) | 14.7% |
| Sharpe ratio (3 years) | 1.10 |
Past returns do not guarantee future results.
IDHQ: frequently asked questions
What does IDHQ invest in?
Invesco S&P International Developed Quality ETF invests in a portfolio of securities. Its largest holdings are Roche Holding AG (5.1%), ASML Holding N.V. (4.8%), Novartis AG (4.4%), Nestle S.A. (3.3%), Advantest Corp. (3.2%).
What is the IDHQ expense ratio?
0.30% a year: about $30.00 for every $10,000 invested.
What is the IDHQ dividend yield?
1.92%. ATLAS does not hold the exact distribution dates for ETFs.
Will IDHQ go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 56%, with a likely range (50%) of $43.67 to $45.73 from $44.46 today. It is a probability, not a prediction.
How has IDHQ performed?
Year to date +26.2%, one year +31.3%, three years +20.5% a year, five years +10.5% a year. Past returns do not guarantee future results.
Similar ETFs: International developed
- Vanguard FTSE Developed Markets ETF (VEA)
- iShares Core MSCI EAFE ETF (IEFA)
- Vanguard Total International Stock ETF (VXUS)
- iShares MSCI EAFE ETF (EFA)
- Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU)
- Schwab International Equity ETF (SCHF)
- iShares Core MSCI Total International Stock ETF (IXUS)
- State Street SPDR Portfolio Developed World ex-US ETF (SPDW)
Educational information, not investment advice. Disclaimer